title: Preservation of fertility in females with haematological malignancy.
abstract: Several options are currently available for the preservation of fertility in cancer patients: embryo cryopreservation, oocyte cryopreservation or ovarian tissue cryopreservation. The choice of the most suitable strategy for preserving fertility depends on different parameters: the type and timing of chemotherapy, the type of cancer, the patient's age and the partner status. Cryopreservation of ovarian tissue is the only option available for prepubertal girls and woman who cannot delay the start of chemotherapy. So far, 15 live births have been obtained after orthotopic transplantation of cryopreserved ovarian tissue.
authors.affiliation: Department of Gynecology, Université Catholique de Louvain, Brussels, Belgium. jacques.donnez@uclouvain.be
authors.forename: Jacques
authors.initials: J
authors.lastname: Donnez
authors.forename: Marie-Madeleine
authors.initials: MM
authors.lastname: Dolmans
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D026688:Bioethical Issues; D015925:Cryopreservation / Q000941:ethics / Q000379:methods; D005260:Female; D005298:Fertility; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D007247:Infertility, Female / Q000139:chemically induced / Q000517:prevention & control*; D010053:Ovary / Q000637:transplantation; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents